Xconomy National

Archives

by in

Entry	Author	Date	Location
OncoSec Medical Advancing Inovio’s Technology Against Cancer	Bruce V. Bigelow	02/08/12	San Diego
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M	Bruce V. Bigelow	02/07/12	San Diego
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
San Diego Life Sciences Strengthened in Recession, Outpacing Nation	Bruce V. Bigelow	02/01/12	San Diego
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says	Luke Timmerman	02/01/12	Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News	Erin Kutz	02/01/12	Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug	Luke Timmerman	01/31/12	Boston
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic	Luke Timmerman	01/31/12	San Diego
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation	Luke Timmerman	01/27/12	Seattle
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
San Diego Life Sciences Roundup: Illumina, Sequenom, Acutus, & More	Bruce V. Bigelow	01/26/12	San Diego
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly	Luke Timmerman	01/25/12	San Francisco
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race	Luke Timmerman	01/24/12	Boston
Novo Nordisk Adds Diabetes Research to Seattle Immunology Team	Luke Timmerman	01/23/12	Seattle
Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx	Luke Timmerman	01/23/12	Boston
Infinity Offers Hint Of Effect With Pancreatic Cancer Drug	Luke Timmerman	01/20/12	Boston
Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade	Luke Timmerman	01/20/12	Boston
San Diego VC Activity at Ebb Tide in 2011 and Top 10 Local Deals	Bruce V. Bigelow	01/20/12	San Diego
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center	Bruce V. Bigelow	01/19/12	San Diego
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis	Luke Timmerman	01/19/12	Seattle
Global Healthcare	Dennis Purcell	01/18/12	New York
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge	Luke Timmerman	01/17/12	San Francisco
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership	Luke Timmerman	01/17/12	San Francisco
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks	Luke Timmerman	01/17/12	National
Seattle Genetics Sees Updated Side Effect Warning in Drug Label	Luke Timmerman	01/13/12	Seattle
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More	Erin Kutz	01/13/12	Boston
Page 1 of 52	next page »